Stream Link:
8pm: https://globalmeet.webcasts.com/starthere.jsp?ei=1719620&tp_key=9a9a0ab66c
Program Description
Anemia is a common complication in patients with inflammatory bowel disease (IBD). Patients with active IBD often experience chronic intestinal inflammation, which can affect appetite and contribute to a decrease in dietary iron intake as well as malabsorption. Iron replacement therapies in IBD aim to normalize hemoglobin levels and iron stores and improve quality of life (QoL) with treatment approaches involving the administration of oral or intravenous iron formulations. Pharmacists must be familiar with how to navigate the selection of these therapies for patients with IBD based on factors such as the acuteness of the anemia, product availability and costs, and patient preference and tolerability. This webinar will review guideline-recommended treatment for iron deficiency anemia in patients with IBD to equip pharmacists, through protocols, to promptly identify this complication and make preventive recommendations or initiate appropriate iron replacement therapies. This webinar is part of the Iron Deficiency Anemia Webinar series.
Target audience: Ambulatory care pharmacist, oncology pharmacist, community pharmacist, health system pharmacist
Type of activity: Application
Release date: June 24, 2025
Expiration date: August 24, 2025
Time to complete activity: 1.0 hours
Learner level: Introductory
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the assessment of iron deficiency and iron deficiency anemia (IDA) in inflammatory bowel disease (IBD) and mechanisms that contribute to its onset.
- Differentiate iron replacement therapies.
- Develop patient-specific treatment plans for IDA in patients with IBD.
TBD
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number TBD. The activity is available for CE credit through TBD.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
TBD
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Adam Welch, PharmD, MBA, FAPhA; Victoria Chirdo; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms